Cargando...
From Traditional to Targeted Immunotherapy in Myasthenia Gravis: Prospects for Research
Treatment of Myasthenia Gravis (MG) is still based on non-specific immunosuppression. Long-term high dose corticosteroids is still a major cause of side effects, in young as well as in elderly patients in whom comorbidities further increase the burden of chronic immunosuppression. Moreover, awarenes...
Guardado en:
| Publicado en: | Front Neurol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7492201/ https://ncbi.nlm.nih.gov/pubmed/32982957 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.00981 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|